Modulatory effects of sesamol in dinitrochlorobenzene-induced inflammatory bowel disorder in albino rats

Pharmacological Reports

Volumn 65, Issue 3, 2013, Pages 658-665

  Kondamudi, Phani Krishna ^a   Kovelamudi, Hemalatha ^a   Mathew, Geetha ^a   Nayak, Pawan G ^a   Mallikarjuna Rao, C ^a   Shenoy, Rekha R ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Dinitrochlorobenzene; Interleukin 6; Myeloperoxidase; Sesamol; TBARS; TNF

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ANTIINFLAMMATORY AGENT; INTERLEUKIN 6; MYELOPEROXIDASE; NITRITE; OXIDIZING AGENT; SALAZOSULFAPYRIDINE; SESAMOL; THIOBARBITURIC ACID REACTIVE SPECIES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; ENTERITIS; HISTOPATHOLOGY; MALE; NONHUMAN; ORGAN WEIGHT; RAT; TISSUE CHARACTERIZATION;

ANIMALS; ANTIOXIDANTS; BENZODIOXOLES; BODY WEIGHT; COLON; DINITROCHLOROBENZENE; GRANULOCYTE COLONY-STIMULATING FACTOR; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-3; INTERLEUKIN-6; MALE; NITRITES; PHENOLS; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884489093     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71043-0     Document Type: Article

References (37)

1. Ainley C, Cason J, Slavin BM, Wolstencroft RA, Thompson RP: The influence of zinc status and malnutrition on immunological function in Crohn's disease. Gastroenterology, 1991, 100, 1616-1625.
2. Anand B, Sunita J: Treatment of inflammatory bowel disease (IBD). Pharmacol Rep, 2011, 63, 629-642.
3. Asquith P, Stokes PL, Mackintosh P, Holmes GKT, Cooke WT: Histocompatibility antigens in patients with inflammatory bowel disease. Lancet, 1974, 303, 113-115.
4. Bobin-Dubigeon C, Collin X, Grimaud N, Robert J-M, Le Baut G, Petit J-Y: Effects of tumour necrosis factor-α synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis. Eur J Pharmacol, 2001, 431, 103-110. (Pubitemid 33082157)
5. Bouma G, Strober W: The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol, 2003, 3, 521-533. (Pubitemid 37328672)
6. Chavali SR, Utsunomiya T, Forse RA: Increased survival after cecal ligation and puncture inmice consuming diets enriched with sesame seed oil. Crit Care Med, 2001, 29, 140.
7. Cosnes J, Beaugerie L, Carbonnel F, Gendre JP: Smoking cessation and the course of Crohn's disease-an intervention study. Gastroenterology, 2001, 120, 1093-1099. (Pubitemid 32246663)
8. Farmer R, Michener W: Association of inflammatory bowel disease in families. Front Gastrointest Res, 1986, 11, 17-26.
9. Hagar HH, El Medany A, El Eter E, Arafa M: Ameliorative effect of pyrrolidinedithiocarbamate on acetic acidinduced colitis in rats. Eur J Pharmacol, 2007, 554, 69-77. (Pubitemid 44822587)
10. Han N, Li G, Kang R, Li Q, Liu Z, Jiang S, Yin J: Treatment of Suqingwan watered pill reduces colon injury induced by experimental colitis. J Ethnopharmacol, 2011, 136, 144-148.
11. Hanauer SB: Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis, 2006, 12, S3-S9. (Pubitemid 43068428)
12. Holmes EW, Yong SL, Eiznhamer D, Keshavarzian A: Glutathione content of colonic mucosa (evidence for oxidative damage in active ulcerative colitis). Dig Dis Sci, 1998, 43, 1088-1095. (Pubitemid 28211471)
13. Hsu DZ, Chen KT, Li YH, Chuang YC, Liu MY: Sesamol delays mortality and attenuates hepatic injury after cecal ligation and puncture in rats: role of oxidative stress. Shock, 2006, 25, 528.
14. Irvine EJ, Marshall JK: Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology, 2000, 119, 1740-1744. (Pubitemid 32198699)
15. Jan K-C, Ho C-T, Hwang LS: Bioavailability and tissue distribution of sesamol in rat. J Agric Food Chem, 2008, 56, 7032-7037.
16. Kang M-H, Naito M, Tsujihara N, Osawa T: Sesamolin inhibits lipid peroxidation in rat liver and kidney. J Nutr, 1998, 128, 1018-1022. (Pubitemid 28280203)
17. Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, Zhang Y, Fields JZ: Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut, 2003, 52, 720-728. (Pubitemid 36528876)
18. Keshavarzian A, Morgan G, Sedghi S, Gordon J, Doria M: Role of reactive oxygen metabolites in experimental colitis. Gut, 1990, 31, 786-790. (Pubitemid 20233945)
19. Korzenik JR: Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol, 2005, 39, S59.
20. Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity-Assessment of inflammation in rat and hamster models. Gastroenterology, 1984, 87, 1344-1350. (Pubitemid 15201434)
21. Manju V, Balasubramaniyan V, Nalini N: Rat colonic lipid peroxidation and antioxidant status: the effects of dietary luteolin on 1,2-dimethylhydrazine challenge. Cell Mol Biol Lett, 2005, 10, 535.
22. McCafferty D: Peroxynitrite and inflammatory bowel disease. Gut, 2000, 46, 436-439.
23. Millar A, Rampton D, Chander C, Claxson A, Blades S, Coumbe A, Panetta J et al.: Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut, 1996, 39, 407-415. (Pubitemid 26338530)
24. Papadakis KA, Targan SR: Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med, 2000, 51, 289-298. (Pubitemid 30216038)
25. Parihar VK, Prabhakar KR, Veerapur VP, Kumar MS, Reddy YR, Joshi R, Unnikrishnan MK, Rao CM: Effect of sesamol on radiation-induced cytotoxicity in Swiss albino mice. Mutat Res, 2006, 611, 9-16. (Pubitemid 44780190)
26. Pavlick KP, Laroux FS, Fuseler J, Wolf RE, Gray L, Hoffman J, Grisham MB: Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med, 2002, 33, 311-322. (Pubitemid 34786271)
27. Podolsky DK, Isselbacher KJ: Composition of human colonic mucin-a selective alteration in inflammatory bowel disease. J Clin Invest, 1983, 72, 142-153. (Pubitemid 13026637)
28. Pool MO, Bouma G, Visser JJ, Kolkman JJ, Tran DD, Meuwissen SGM, Peńa AS: Serum nitrate levels in ulcerative colitis and Crohn's disease. Scand J Gastroenterol, 1995, 30, 784-788.
29. Rabin B. Animal model: immunologic model of inflammatory bowel disease. Am J Pathol, 1980, 99, 253.
30. Rabin BS, Rogers SJ: A cell-mediated immune model of inflammatory bowel disease in the rabbit. Gastroenterology, 1978, 75, 29-33. (Pubitemid 8378766)
31. Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, Landers C, Jewell DP: Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology, 1997, 112, 1845-1853. (Pubitemid 27240769)
32. Shenoy RR, Sudheendra AT, Nayak PG, Paul P, Kutty NG, Rao CM: Normal and delayed wound healing is improved by sesamol, an active constituent of Sesamum in-dicum (L.) in albino rats. J Ethnopharmacol, 2011, 133, 608-612.
33. Somerville KW, Logan RF, Edmond M, Langman MJ: Smoking and Crohn's disease. BMJ, 1984, 289, 954-956. (Pubitemid 14011155)
34. Tysk C, Lindberg E, Järnerot G, Floderus-Myrhed B: Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins-Astudy of heritability and the influence of smoking. Gut, 1988, 29, 990-996.
35. Van Der Vliet A, Bast A: Role of reactive oxygen species in intestinal diseases. Free Radic Biol Med, 1992, 12, 499-513.
36. Venkataranganna M, Rafiq M, Gopumadhavan S, Peer G, Babu U, Mitra S: NCB-02 (standardized curcumin preparation) protects dinitrochlorobenzene-induced colitis through down-regulation of NFκ-B and iNOS. World J Gastroenterol, 2007, 13, 1103.
37. Verspaget HW, Mulder TP, van der Sluys Veer A, Pena AS, Lamers CB: Reactive oxygen metabolites and colitis: a disturbed balance between damage and protection-A selective review. Scand J Gastroenterol Suppl, 1991, 188, 44-51.